ParaGard®
T 380A does not protect against HIV/AIDS or other sexually
transmitted diseases. ParaGard® is recommended for women
who have had at least one child, are in a stable, mutually
monogamous relationship, and have no history of pelvic inflammatory
disease (PID). Women with a history of PID should not use
ParaGard®.
Some serious complications that have been
associated with intrauterine contraceptives, including ParaGard®,
are:
• Pelvic inflammatory disease (PID)
• Perforation of the uterus
• Expulsion (where the contraceptive falls completely
or partially out of the uterus)
The highest risk of PID is shortly after placement
in the uterus, usually within the first 20 days. PID can
cause permanent blockage of the tubes, sterility, ectopic
pregnancy, or, in infrequent cases, death. A decision to
use ParaGard® T 380A must include consideration of these
and other possible risks. If you currently have or have
ever had PID, you must not use ParaGard®.
The most common side effects of ParaGard®
T 380A are heavier, longer periods with increased cramping
for a few months after placement; some women have spotting
between periods. For most women, this typically subsides
after a few months. If you ever miss a period, call your
healthcare professional without delay.
Prescribing
Information
Patient
Package Insert
|
